Elekta

OverviewSuggest Edit

Elekta is a medical device company that manufactures radiotherapy solutions for cancer care and brain disorders. It offers solutions in both radiotherapy treatment and oncology informatics systems for oncology clinics.

TypePublic
Founded1972
HQStockholm, SEMap
Websiteelekta.com
Employee Ratings3.5More
Overall CultureC+More
View Jobs (253)

Recent NewsAll News

Latest Updates

Employees (est.) (Apr 2020)4,175(+8%)
Job Openings253
Share Price (Jul 2021)KR122.1
Cybersecurity ratingAMore

Key People/Management at Elekta

Laurent Leksell

Laurent Leksell

Board Chairman and Chairman of the Compensation and Sustainability Committee
Karin Svenske

Karin Svenske

Executive Vice President Human Resources
Birgitta Stymne Göransson

Birgitta Stymne Göransson

Board Member
Maurits Wolleswinkel

Maurits Wolleswinkel

President Linac Solutions
John Lapré

John Lapré

President Brachy Solutions
Paul Bergström

Paul Bergström

Executive Vice President Global Services
Show more

Elekta Office Locations

Elekta has offices in Stockholm, Atlanta, North Sydney, Beijing and in 2 other locations
Stockholm, SE (HQ)
Kungstensgatan 18, 103
North Sydney, AU
Suite 10.2, Level 10/146 Arthur St
Beijing, CN
Room 3202 & 3203, Pangu Plaza, Office Building, Block A, No. 27 Fourth Ring Mid Road, Chaoyang District
Veenendaal, NL
Waardgelder 1
Crawley, GB
London Rd
Atlanta, GA, US
400 Perimeter Center Terrace #50
Show all (6)

Elekta Financials and Metrics

Elekta Revenue

Market capitalization (15-Jul-2021)

46.6b

Closing stock price (15-Jul-2021)

122.1
Elekta's current market capitalization is kr46.6 b.
Show all financial metrics

Elekta Cybersecurity Score

Cybersecurity ratingPremium dataset

A

92/100

Learn more about our premium products
SecurityScorecard logo

Elekta Environment, Social & Governance (ESG) Ratings

CSRHub ESG ratingPremium dataset

60-79

out of 100

Learn more about our premium products
CSRHub logo

Elekta Online and Social Media Presence

Elekta's Trends

Embed Graph

Elekta Company Culture

  • Overall Culture

    C+

    68/100

  • CEO Rating

    C

    65/100

  • Compensation

    B

    75/100

  • Diversity

    B

    73/100

Learn more on Comparably

Elekta News and Updates

July 07, 2021

Elekta optimizes treatment times for cancer patients via proactive service innovation

STOCKHOLM, July 7, 2021 /PRNewswire/ -- For the last several years, Elekta (EKTA-B.ST) has invested substantially in digitized service solutions to keep critical treatment machines up and running at cancer clinics, thereby ensuring that patients receive timely radiotherapy. Among these...
June 17, 2021

Elekta radiotherapy system designed for changing cancer landscape now available for U.S. patients

ATLANTA, June 17, 2021 /PRNewswire/ -- Elekta (EKTA-B.ST) announced today that its Elekta Harmony* radiation therapy system recently received U.S. FDA 510(k) clearance, paving the way for U.S. clinics to harness the system to treat a comprehensive range of indications using the latest...
June 07, 2021

Elekta and Philips deepen strategic partnership in precise and individualized oncology care

STOCKHOLM and AMSTERDAM, June 7, 2021 /PRNewswire/ -- Elekta (EKTA-B.ST) and Royal Philips (NYSE: PHG, AEX: PHIA) today signed agreements to deepen their existing strategic partnership to advance comprehensive and personalized cancer care through precision oncology solutions. The extended...
June 07, 2021

Philips and Elekta deepen strategic partnership in precise and individualized oncology care

June 7, 2021Healthcare leaders partner to streamline the path from cancer diagnosis to survivorship for better outcomes
June 04, 2021

Elekta Nomination Committee's proposed Board of Directors for the 2021 Annual General Meeting

STOCKHOLM, June 4, 2021 /PRNewswire/ -- The Nomination Committee of Elekta (EKTA-B.ST) proposes that the 2021 Annual General Meeting re-elect Board members Laurent Leksell, who is also proposed to be re-elected as Chairman of the Board, Caroline Leksell Cooke, Johan Malmquist, Wolfgang...
June 01, 2021

100th Elekta Unity MR-Linac goes to St George's Hospital in New Zealand

CHRISTCHURCH, New Zealand, June 1, 2021 /PRNewswire/ -- Elekta (EKTA-B.ST) announces that St George's Hospital in Christchurch, New Zealand, has ordered an Elekta Unity MR-Linac, making it the 100th device sold since introduction. Today, the innovative radiation therapy device is found in...
Show more

Elekta Blogs

July 23, 2021

GenesisCare extends U.S. brachytherapy service with 27 Elekta Flexitron treatment devices

June 07, 2021

Elekta's new strategy to focus on growth and access to radiation therapy

Capital Markets Day presentations highlight opportunities and potential based on Elekta's strong position
May 28, 2021

Year-end report, May–April 2020/21

March 11, 2021

Elekta's Board of Directors proposes additional dividend of SEK 0.90 per share

February 25, 2021

Interim report, May–January 2020/21

February 24, 2021

First cancer centers begin using initial release of Elekta's MOSAIQ 3 series

Show more

 Elekta Frequently Asked Questions

  • When was Elekta founded?

    Elekta was founded in 1972.

  • Who are Elekta key executives?

    Elekta's key executives are Laurent Leksell, Karin Svenske and Birgitta Stymne Göransson.

  • How many employees does Elekta have?

    Elekta has 4,175 employees.

  • Who are Elekta competitors?

    Competitors of Elekta include ViewRay, Accuray and Flatiron Health.

  • Where is Elekta headquarters?

    Elekta headquarters is located at Kungstensgatan 18, 103, Stockholm.

  • Where are Elekta offices?

    Elekta has offices in Stockholm, Atlanta, North Sydney, Beijing and in 2 other locations.

  • How many offices does Elekta have?

    Elekta has 6 offices.